e-learning
resources
Munich 2006
Wednesday 06.09.2006
Interstial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A retrospective review to assess the effect of prednisolone and azathioprine on usual interstitial pneumonia disease progression
M. J. Malik, B. E. Ladd, M. T. Henry (Leeds, United Kingdom)
Source:
Annual Congress 2006 - Interstial lung diseases
Session:
Interstial lung diseases
Session type:
Poster Discussion
Number:
4763
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. J. Malik, B. E. Ladd, M. T. Henry (Leeds, United Kingdom). A retrospective review to assess the effect of prednisolone and azathioprine on usual interstitial pneumonia disease progression. Eur Respir J 2006; 28: Suppl. 50, 4763
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicentered open-label study
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
An observational study on effectiveness of azathioprine in treatment of interstitial lung disease secondary to connective tissue disease
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019
Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004
Infliximab therapy in patients with chronic progressive sarcoidosis – a retrospective follow-up study
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia
Source: Eur Respir J 2015; 45: 1624-1631
Year: 2015
Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
A retrospective analysis of methotrexate therapy as a steroid sparing agent within a UK severe asthma clinic
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012
A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?
Source: Eur Respir J, 57 (6) 2004354; 10.1183/13993003.04354-2020
Year: 2021
The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies
Source: Eur Respir J, 51 (6) 1800376; 10.1183/13993003.00376-2018
Year: 2018
Intravenous cyclophosphamide therapy for patients with interstitial pulmonary disease associated with collagen vascular disorders. A single-center experience
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. A retrospective study
Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2011
Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study
Source: Eur Respir J, 55 (4) 1901983; 10.1183/13993003.01983-2019
Year: 2020
The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021
Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005
A retrospective analysis of our lung transplant cohort for the dichotomy within bronchiolitis obliterans syndrome and azithromycin therapy
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009
Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 433s
Year: 2002
Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept